BMJ  2005;330:109 (15 January), doi:10.1136/bmj.330.7483.109

News

Drug companies agree to make clinical trial results public

London

The first 150 words of the full text of this article appear below.

Pharmaceutical companies around the world have agreed to make results from clinical trials of new prescription medicines publicly available, it was announced last week.

The voluntary agreement has been drawn up by the world's main pharmaceutical industry trade associations and agreed by key companies. It states that summary results of completed, industry sponsored clinical trials will be publicly disclosed on free and publicly accessible databases, regardless of outcome, for any medicine approved for marketing in at least one country.

The results will be published in a standard, non-promotional summary that will include a description of trial design and methods, results of primary and secondary outcome measures described in the protocol, and safety results. Each company can select the website where they publish trial results, but if they are published in a peer reviewed journal, the database will include a link to the relevant article.

For medicines not yet approved or . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Next steps in trial registration

Kamran Abbasi and Fiona Godlee
BMJ 2005 330: 1222-1223. [Extract] [Full Text] [PDF]

Trial results: the next battle

Kamran Abbasi
BMJ 2005 330: 0. [Extract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Broad support from the Institute of Clinical Research, but other sponsors should follow suit

Andrew M Smith
bmj.com, 14 Jan 2005 [Full text]

Online poll

Find out more >>